Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (141-150 of 260) with videos related to

Pageof 26
Sort By:
American Journal of Hematology|February 12, 2024
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trialMary Eapen, Jianqun Kou, Martin Andreansky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2012
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levelsJakub Tolar, H Joachim Deeg, Sally Arai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Blood Advances|June 24, 2025
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practiceNeel S Bhatt, Azra Borogovac, Yvonne A Efebera, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant RegistryDonald A Berry, Gloria Broadwater, John P Klein, et al.
The Lancet. Haematology|December 22, 2015
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation studyPaolo Anderlini, Juan Wu, Iris Gersten, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
British Journal of Haematology|February 21, 2006
Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant ResearchHillard M Lazarus, Waleska S Pérez, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe StudyGalen E Switzer, Jessica G Bruce, Deidre M Kiefer, et al.
Pageof 26

Showing results (141-150 of 260) with videos related to

Sort By:
Pageof 26
American Journal of Hematology|February 12, 2024
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trialMary Eapen, Jianqun Kou, Martin Andreansky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2012
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levelsJakub Tolar, H Joachim Deeg, Sally Arai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Blood Advances|June 24, 2025
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practiceNeel S Bhatt, Azra Borogovac, Yvonne A Efebera, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant RegistryDonald A Berry, Gloria Broadwater, John P Klein, et al.
The Lancet. Haematology|December 22, 2015
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation studyPaolo Anderlini, Juan Wu, Iris Gersten, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
British Journal of Haematology|February 21, 2006
Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant ResearchHillard M Lazarus, Waleska S Pérez, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 24, 2020
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe StudyGalen E Switzer, Jessica G Bruce, Deidre M Kiefer, et al.
Pageof 26